This page has been archived on the Web

Information identified as archived is provided for reference, research or recordkeeping purposes. It is not subject to the Government of Canada Web Standards and has not been altered or updated since it was archived. Please contact us to request a format other than those available.

Archived

This page has been archived on the Web.

Health product recall

Acet 650

Starting date:
June 21, 2013
Posting date:
July 17, 2013
Type of communication:
Drug Recall
Subcategory:
Drugs
Hazard classification:
Type I
Source of recall:
Health Canada
Issue:
Product Safety
Audience:
General Public, Healthcare Professionals, Hospitals
Identification number:
RA-34613

Recalled products

  1. Acet 650

Reason

A labelling error was found on these lots. Although the box of the product indicates a dosage of 650 mg and that the suppositories contained in the box have a dosage of 650 mg, the printed inscription on certain blisters erroneously indicates a dosage of 325 mg.

Depth of distribution

Wholesalers in Canada.

Affected products

A. Acet 650

DIN, NPN, DIN-HIM
DIN 02230437
Dosage form

Suppository

Strength
  • 650 mg
Lot or serial number
  • L929
  • L930
Companies
Recalling Firm
Pendopharm
Division of Pharmascience Inc.
8580 Esplanade Ave.
Montreal
H2P 2R8
Quebec
CANADA
Marketing Authorization Holder
Pendopharm
Division of Pharmascience Inc.
8580 Esplanade Ave.
Montreal
H2P 2R8
Quebec
CANADA

Date modified: